- Report
- November 2024
Global
From €12663EUR$14,500USD£11,001GBP
- Report
- September 2022
Philippines
From €1616EUR$1,850USD£1,404GBP
- Report
- August 2022
Latin America
From €12663EUR$14,500USD£11,001GBP
- Report
- August 2022
Asia Pacific
From €12663EUR$14,500USD£11,001GBP
- Report
- December 2021
Jordan
From €1616EUR$1,850USD£1,404GBP
The Immunoglobulin M (IgM) Test is a type of In Vitro Diagnostics (IVD) used to detect the presence of IgM antibodies in a patient's blood. IgM antibodies are the first antibodies to be produced in response to an infection, and their presence can indicate a recent or current infection. IgM tests are used to diagnose a variety of infectious diseases, including HIV, hepatitis, and Lyme disease.
IgM tests are typically performed in a laboratory setting, and the results are used to inform diagnosis and treatment decisions. The test is often used in combination with other tests, such as IgG tests, to provide a more comprehensive picture of a patient's health.
The IgM Test market is a growing segment of the IVD market, with a variety of companies offering products and services. Companies in the market include Abbott, Roche, Siemens, and Bio-Rad. Show Less Read more